The total return over the past 12 months is +46.32% vs. +22.54% for the S&P 500. So far it's up +28.28% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +45.86% | (4.18%) | (3.69%) | +15.75% | +21.00% | +15.86% |
| Total Return CAGR | +46.32% | (3.91%) | (3.44%) | +16.17% | +21.74% | +16.82% |
| Revenue CAGR | +12.39% | +5.10% | +5.68% | +8.63% | +7.33% | +7.12% |
| Net Income CAGR | +15.83% | +2.88% | +1.70% | +18.71% | +15.68% | +12.03% |
| EPS CAGR | +17.11% | (4.65%) | +7.85% | +17.77% | +13.82% | +11.68% |
| Free Cash Flow CAGR | +27.01% | +3.26% | +8.74% | +20.54% | +13.54% | +11.53% |
| Operating Cash Flow CAGR | (2.14%) | (2.16%) | +5.76% | +11.86% | +10.69% | +9.31% |
| Dividends CAGR | +4.94% | +5.20% | +5.51% | +6.57% | +6.62% | +6.87% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
West Pharmaceutical Services, Inc. (WST)
| Year | Start price | End price | WST Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $275.14 | $352.13 | +28.28% | +13.96% | +14.32% |
| 2025 | $327.56 | $275.14 | (15.73%) | +17.72% | (33.45%) |
| 2024 | $352.12 | $327.56 | (6.76%) | +24.89% | (31.65%) |
| 2023 | $235.35 | $352.12 | +49.97% | +26.19% | +23.78% |
| 2022 | $469.01 | $235.35 | (49.70%) | (18.17%) | (31.53%) |
| 2021 | $283.31 | $469.01 | +65.88% | +28.74% | +37.14% |
| 2020 | $150.33 | $283.31 | +89.06% | +18.37% | +70.69% |
| 2019 | $98.03 | $150.33 | +54.14% | +31.22% | +22.92% |
| 2018 | $98.67 | $98.03 | (0.08%) | (4.56%) | +4.48% |
| 2017 | $84.83 | $98.67 | +17.02% | +21.70% | (4.68%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
